| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 81,35 | 81,55 | 22:09 | |
| 81,30 | 81,65 | 22:00 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 86,00 | 159 | |||
| 85,00 | 330 | |||
| 84,00 | 70 | |||
| 82,80 | 100 | |||
| 82,50 | 160 | |||
| 82,40 | 200 | |||
| 82,00 | 32 | |||
| 81,75 | 54 | |||
| 81,65 | 54 | |||
| 81,55 | 314 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/22ua.htm [/URL] | ||||
| 104 | 81,30 | |||
| 210 | 80,85 | |||
| 54 | 80,75 | |||
| 54 | 80,65 | |||
| 50 | 78,00 | |||
| 147 | 77,90 | |||
| 10 | 77,00 | |||
| 100 | 76,50 | |||
| 100 | 76,00 | |||
| 3 | 75,70 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 832 | 1,770 | 1.473 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:46 | 79,55 | 1.241 |
| 17:27:25 | 79,60 | 52 |
| 17:27:25 | 79,65 | 120 |
| 17:26:00 | 79,70 | 66 |
| 17:24:43 | 79,80 | 14 |
| 17:24:43 | 79,70 | 203 |
| 17:22:26 | 79,75 | 30 |
| 17:21:26 | 79,70 | 19 |
| 17:21:26 | 79,70 | 7 |
| 17:20:45 | 79,65 | 32 |
| 17:20:28 | 79,60 | 30 |
| 17:16:07 | 79,50 | 119 |
| 17:16:07 | 79,35 | 239 |
| 17:16:07 | 79,30 | 224 |
| 17:15:24 | 79,30 | 53 |
| 17:14:51 | 79,35 | 205 |
| 17:14:34 | 79,40 | 241 |
| 17:13:46 | 79,50 | 29 |
| 17:13:45 | 79,40 | 61 |
| 17:12:47 | 79,45 | 1 |
| Tagesumsatz Xetra | +1,75 +2,25 % | 28.668 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:30 | Curevac im Fokus: Was erfahrene Anleger vor dem Wochenende genau beobachten - Meine klare Einschätzung dazu | Hebelschein-Spekulant | |||
| Di | Top-Investoren umwerben neues Projekt von Biontech-Gründern - ohne es zu kennen | 113 | FOCUS | ||
| BIONTECH Aktie jetzt für 0€ handeln | |||||
| Di | Bill Gates offenbar an neuem Projekt der Biontech-Gründer interessiert | 128 | manager-magazin.de | ||
| Di | Leerink senkt Kursziel für BioNTech wegen Bedenken bei Medikamentenstudie | 251 | Investing.com Deutsch | ||
| Di | Leerink cuts BioNTech stock price target on drug trial concerns | 66 | Investing.com |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 14:30 | MetaVia Inc.: MetaVia Doses the First Patient in Higher-Dose Phase 1 Study of DA-1726, Its GLP-1 and Glucagon Dual Agonist for the Treatment of Obesity | PR Newswire | 16-Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults
CAMBRIDGE, Mass., April 10, 2026... ► Artikel lesen | |
| 11:57 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 11:51 | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| 16:18 | Weekly Buzz: MacroGenics Resumes LINNET; GSK Wins China Nod; FDA Okays Waters Corporation; Neurocrine Biosciences Snaps Up Soleno Therapeutics | AFX News | THOUSAND OAKS (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S., Canada, and China, alongside the lifting of a clinical trial hold by the FDA, collaborations... ► Artikel lesen | |
| 20:29 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.04.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 10.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.04.2026.ISIN NameAU000000ICI5... ► Artikel lesen |